SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001600620-23-000018
Filing Date
2023-05-23
Accepted
2023-05-23 17:16:00
Documents
1
Period of Report
2023-05-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1684876541.html 4  
1 FORM 4 wk-form4_1684876541.xml 4 10477
  Complete submission text file 0001600620-23-000018.txt   11782
Mailing Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6
Business Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6 250-744-2487
Aurinia Pharmaceuticals Inc. (Issuer) CIK: 0001600620 (see all company filings)

IRS No.: 981231763 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address #1203-4464 MARKHAM STREET VICTORIA A1 V8Z7X8
Business Address
MacKay-Dunn R. Hector (Reporting) CIK: 0001838521 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36421 | Film No.: 23949821